Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 414

1.

Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.

Htay H, Johnson DW, Craig JC, Schena FP, Strippoli GF, Tong A, Cho Y.

Cochrane Database Syst Rev. 2019 May 31;5:CD004680. doi: 10.1002/14651858.CD004680.pub3.

PMID:
31149735
2.

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA; Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.

PMID:
30635226
3.

Biomarkers and Precision Medicine in IgA Nephropathy.

Schena FP, Cox SN.

Semin Nephrol. 2018 Sep;38(5):521-530. doi: 10.1016/j.semnephrol.2018.05.022. Review.

PMID:
30177024
4.

Epidemiology of IgA Nephropathy: A Global Perspective.

Schena FP, Nistor I.

Semin Nephrol. 2018 Sep;38(5):435-442. doi: 10.1016/j.semnephrol.2018.05.013.

PMID:
30177015
5.

Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.

Schena FP, Serino G, Sallustio F, Falchi M, Cox SN.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2101-2112. doi: 10.1093/ndt/gfy130.

PMID:
29905852
6.

A transcriptomics study of hereditary angioedema attacks.

Castellano G, Divella C, Sallustio F, Montinaro V, Curci C, Zanichelli A, Bonanni E, Suffritti C, Caccia S, Bossi F, Gallone A, Schena FP, Gesualdo L, Cicardi M.

J Allergy Clin Immunol. 2018 Sep;142(3):883-891. doi: 10.1016/j.jaci.2018.03.016. Epub 2018 May 4.

PMID:
29729940
7.

Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review.

Schena FP, Nistor I, Curci C.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1094-1102. doi: 10.1093/ndt/gfx211.

PMID:
28992289
8.

Inhibin-A and Decorin Secreted by Human Adult Renal Stem/Progenitor Cells Through the TLR2 Engagement Induce Renal Tubular Cell Regeneration.

Sallustio F, Curci C, Aloisi A, Toma CC, Marulli E, Serino G, Cox SN, De Palma G, Stasi A, Divella C, Rinaldi R, Schena FP.

Sci Rep. 2017 Aug 15;7(1):8225. doi: 10.1038/s41598-017-08474-0.

9.

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma.

De Palma G, Sallustio F, Curci C, Galleggiante V, Rutigliano M, Serino G, Ditonno P, Battaglia M, Schena FP.

J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016.

10.

Cultivar classification of Apulian olive oils: Use of artificial neural networks for comparing NMR, NIR and merceological data.

Binetti G, Del Coco L, Ragone R, Zelasco S, Perri E, Montemurro C, Valentini R, Naso D, Fanizzi FP, Schena FP.

Food Chem. 2017 Mar 15;219:131-138. doi: 10.1016/j.foodchem.2016.09.041. Epub 2016 Sep 7.

PMID:
27765209
11.

Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation.

Parodi F, Carosio R, Ragusa M, Di Pietro C, Maugeri M, Barbagallo D, Sallustio F, Allemanni G, Pistillo MP, Casciano I, Forlani A, Schena FP, Purrello M, Romani M, Banelli B.

Biochim Biophys Acta. 2016 Dec;1859(12):1502-1514. doi: 10.1016/j.bbagrm.2016.10.006. Epub 2016 Oct 15.

PMID:
27751904
12.

Multiple rare genetic variants co-segregating with familial IgA nephropathy all act within a single immune-related network.

Cox SN, Pesce F, El-Sayed Moustafa JS, Sallustio F, Serino G, Kkoufou C, Giampetruzzi A, Ancona N, Falchi M, Schena FP; European IgAN Consortium.

J Intern Med. 2017 Feb;281(2):189-205. doi: 10.1111/joim.12565. Epub 2016 Oct 11.

13.

Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases.

De Palma G, Sallustio F, Schena FP.

Int J Mol Sci. 2016 Jun 30;17(7). pii: E1043. doi: 10.3390/ijms17071043. Review.

14.

Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection.

Curci C, Sallustio F, Serino G, De Palma G, Trpevski M, Fiorentino M, Rossini M, Quaglia M, Valente M, Furian L, Toscano A, Mazzucco G, Barreca A, Bussolino S, Gesualdo L, Stratta P, Rigotti P, Citterio F, Biancone L, Schena FP.

Nephrol Dial Transplant. 2016 Dec;31(12):2131-2142. Epub 2016 Jul 1.

PMID:
27369853
15.

IgA nephropathy.

Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ.

Nat Rev Dis Primers. 2016 Feb 11;2:16001. doi: 10.1038/nrdp.2016.1. Review.

PMID:
27189177
16.

Micropatterning control of tubular commitment in human adult renal stem cells.

Sciancalepore AG, Portone A, Moffa M, Persano L, De Luca M, Paiano A, Sallustio F, Schena FP, Bucci C, Pisignano D.

Biomaterials. 2016 Jul;94:57-69. doi: 10.1016/j.biomaterials.2016.03.042. Epub 2016 Mar 31.

PMID:
27105437
17.

Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.

Inker LA, Mondal H, Greene T, Masaschi T, Locatelli F, Schena FP, Katafuchi R, Appel GB, Maes BD, Li PK, Praga M, Del Vecchio L, Andrulli S, Manno C, Gutierrez E, Mercer A, Carroll KJ, Schmid CH, Levey AS.

Am J Kidney Dis. 2016 Sep;68(3):392-401. doi: 10.1053/j.ajkd.2016.02.042. Epub 2016 Mar 29.

PMID:
27032886
18.

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Schena FP, Manno C.

N Engl J Med. 2016 Mar 10;374(10):992. doi: 10.1056/NEJMc1600141. No abstract available.

PMID:
26962739
19.

Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?

Nerini E, Bruno F, Citterio F, Schena FP.

J Nephrol. 2016 Oct;29(5):627-36. doi: 10.1007/s40620-016-0273-x. Epub 2016 Feb 17. Review.

PMID:
26885659
20.

Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy.

Sallustio F, Serino G, Cox SN, Dalla Gassa A, Curci C, De Palma G, Banelli B, Zaza G, Romani M, Schena FP.

Clin Sci (Lond). 2016 May;130(9):733-46. doi: 10.1042/CS20150711. Epub 2016 Feb 4.

PMID:
26846681
21.

Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics.

Ragone R, Sallustio F, Piccinonna S, Rutigliano M, Vanessa G, Palazzo S, Lucarelli G, Ditonno P, Battaglia M, Fanizzi FP, Schena FP.

Diseases. 2016 Jan 22;4(1). pii: E7. doi: 10.3390/diseases4010007.

22.

Robustness of NMR-based metabolomics to generate comparable data sets for olive oil cultivar classification. An inter-laboratory study on Apulian olive oils.

Piccinonna S, Ragone R, Stocchero M, Del Coco L, De Pascali SA, Schena FP, Fanizzi FP.

Food Chem. 2016 May 15;199:675-83. doi: 10.1016/j.foodchem.2015.12.064. Epub 2015 Dec 15.

PMID:
26776024
23.

Role of miR-422a and kallikrein-related peptidase 4 implicated in the development of lupus nephritis. Do we work in this direction?

Serino G, Curci C, Schena FP.

Nephrol Dial Transplant. 2016 May;31(5):683-5. doi: 10.1093/ndt/gfv396. Epub 2015 Nov 27. Review. No abstract available.

PMID:
26614269
24.

In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.

Serino G, Pesce F, Sallustio F, De Palma G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, Papagianni A, Stangou M, Goumenos D, Gerolymos M, Takahashi K, Yuzawa Y, Maruyama S, Imai E, Schena FP.

Kidney Int. 2016 Mar;89(3):683-92.

PMID:
26581012
25.

Patient classification and outcome prediction in IgA nephropathy.

Diciolla M, Binetti G, Di Noia T, Pesce F, Schena FP, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Naso D.

Comput Biol Med. 2015 Nov 1;66:278-86. doi: 10.1016/j.compbiomed.2015.09.003. Epub 2015 Sep 25.

PMID:
26453758
26.

[Cardiovascular risk in polycystic kidney disease].

Di Lorenzo A, Stallone G, Infante B, Grandaliano G, Schena FP.

G Ital Cardiol (Rome). 2015 Sep;16(9):479-84. doi: 10.1714/1988.21520. Italian.

PMID:
26418387
27.

Potential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney Injury.

Sallustio F, Serino G, Schena FP.

Biores Open Access. 2015 Jul 1;4(1):326-33. doi: 10.1089/biores.2015.0011. eCollection 2015. Review.

28.

Immunosuppressive agents for treating IgA nephropathy.

Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.

Cochrane Database Syst Rev. 2015 Aug 3;(8):CD003965. doi: 10.1002/14651858.CD003965.pub2. Review.

PMID:
26235292
29.

Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.

Pesce F, Diciolla M, Binetti G, Naso D, Ostuni VC, Di Noia T, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Di Sciascio E, Schena FP.

Nephrol Dial Transplant. 2016 Jan;31(1):80-6. doi: 10.1093/ndt/gfv232. Epub 2015 Jun 4.

PMID:
26047632
30.

Correction: A bioartificial renal tubule device embedding human renal stem/progenitor cells.

Sciancalepore AG, Sallustio F, Girardo S, Passione LG, Camposeo A, Mele E, Di Lorenzo M, Costantino V, Schena FP, Pisignano D.

PLoS One. 2015 May 8;10(5):e0128261. doi: 10.1371/journal.pone.0128261. eCollection 2015. No abstract available.

31.

Correction: miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells.

Sallustio F, Serino G, Costantino V, Curci C, Cox SN, De Palma G, Schena FP.

PLoS One. 2015 May 8;10(5):e0128258. doi: 10.1371/journal.pone.0128258. eCollection 2015. No abstract available.

32.

microRNAs in glomerular diseases from pathophysiology to potential treatment target.

Schena FP, Sallustio F, Serino G.

Clin Sci (Lond). 2015 Jun;128(11):775-88. doi: 10.1042/CS20140733. Review.

PMID:
25881669
33.

Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients.

Cox SN, Serino G, Sallustio F, Blasi A, Rossini M, Pesce F, Schena FP.

Nephrol Dial Transplant. 2015 Jul;30(7):1122-232. doi: 10.1093/ndt/gfv017. Epub 2015 Mar 13.

PMID:
25770168
34.

Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy.

Serino G, Sallustio F, Curci C, Cox SN, Pesce F, De Palma G, Schena FP.

Nephrol Dial Transplant. 2015 Jul;30(7):1132-9. doi: 10.1093/ndt/gfv032. Epub 2015 Mar 4.

PMID:
25744272
35.

Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients.

Sallustio F, Cox SN, Serino G, Curci C, Pesce F, De Palma G, Papagianni A, Kirmizis D, Falchi M, Schena FP; European IgAN Consortium.

Eur J Hum Genet. 2015 Jul;23(7):940-8. doi: 10.1038/ejhg.2014.208. Epub 2014 Oct 8.

36.

Biomarkers and personalized therapy in chronic kidney diseases.

Schena FP.

Expert Opin Investig Drugs. 2014 Aug;23(8):1051-4. doi: 10.1517/13543784.2014.922953. Epub 2014 May 26.

PMID:
24857812
37.

A bioartificial renal tubule device embedding human renal stem/progenitor cells.

Sciancalepore AG, Sallustio F, Girardo S, Gioia Passione L, Camposeo A, Mele E, Di Lorenzo M, Costantino V, Schena FP, Pisignano D.

PLoS One. 2014 Jan 30;9(1):e87496. doi: 10.1371/journal.pone.0087496. eCollection 2014. Erratum in: PLoS One. 2014; 9(6): e100141. PLoS One. 2015;10(5):e0128261.

38.

Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients.

Zaza G, Granata S, Masola V, Rugiu C, Fantin F, Gesualdo L, Schena FP, Lupo A.

PLoS One. 2013 Oct 28;8(10):e77847. doi: 10.1371/journal.pone.0077847. eCollection 2013.

39.

A comparative study of covariance selection models for the inference of gene regulatory networks.

Stifanelli PF, Creanza TM, Anglani R, Liuzzi VC, Mukherjee S, Schena FP, Ancona N.

J Biomed Inform. 2013 Oct;46(5):894-904. doi: 10.1016/j.jbi.2013.07.002. Epub 2013 Jul 20.

40.

miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells.

Sallustio F, Serino G, Costantino V, Curci C, Cox SN, De Palma G, Schena FP.

PLoS One. 2013 Jul 8;8(7):e68296. doi: 10.1371/journal.pone.0068296. Print 2013. Erratum in: PLoS One. 2015;10(5):e0128258.

41.

MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring.

Schena FP, Serino G, Sallustio F.

Nephrol Dial Transplant. 2014 Apr;29(4):755-63. doi: 10.1093/ndt/gft223. Epub 2013 Jun 19. Review.

PMID:
23787546
42.

A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients.

Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL.

Transplantation. 2013 May 27;95(10):1233-41. doi: 10.1097/TP.0b013e318291a269.

PMID:
23689085
43.

Increasing relevance of donor-specific antibodies in antibody-mediated rejection.

Zito A, Schena A, Grandaliano G, Gesualdo L, Schena FP.

J Nephrol. 2013 Mar-Apr;26(2):237-42. doi: 10.5301/jn.5000240. Epub 2012 Dec 20. Review.

PMID:
23475460
44.

Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin.

Sallustio F, Costantino V, Cox SN, Loverre A, Divella C, Rizzi M, Schena FP.

Kidney Int. 2013 Mar;83(3):392-403. doi: 10.1038/ki.2012.413. Epub 2013 Jan 16. Retraction in: Kidney Int. 2015 Feb;87(2):482.

45.

From -omics to personalized medicine in nephrology: integration is the key.

Pesce F, Pathan S, Schena FP.

Nephrol Dial Transplant. 2013 Jan;28(1):24-8. doi: 10.1093/ndt/gfs483. Epub 2012 Dec 9. Review.

PMID:
23229923
46.

Lymphoma presenting as Henoch-Schönlein purpura.

Schena FP, Soerjadi N, Zwi J, de Zoysa JR.

Clin Kidney J. 2012 Dec;5(6):600-2. doi: 10.1093/ckj/sfs128. Epub 2012 Nov 6. No abstract available.

47.

Pre-eclampsia before 20-week gestation: diagnosis, investigation and management.

Schena FP, Thomas W, Griffiths M, Nelson-Piercy C, Sinnamon K.

Clin Kidney J. 2012 Dec;5(6):597-9. doi: 10.1093/ckj/sfs101. Epub 2012 Oct 15. No abstract available.

48.

Please advise on infusing hydrochloric acid.

Schena FP, Kettritz R, Luft FC.

Clin Kidney J. 2012 Dec;5(6):595-6. doi: 10.1093/ckj/sfs112. Epub 2012 Oct 24. No abstract available.

49.

Renal injury due to anti-glomerular basement membrane antibody-mediated glomerulonephritis without circulating antibody.

Schena FP, Dash A, Fatima H, Grewal M, Galphin C, Paueksakon P.

Clin Kidney J. 2012 Dec;5(6):591-4. doi: 10.1093/ckj/sfs106. Epub 2012 Oct 19. No abstract available.

50.

Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G, Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F; Immunosuppression and Cancer Study Group.

Eur J Cancer. 2013 Jan;49(2):336-44. doi: 10.1016/j.ejca.2012.09.013. Epub 2012 Oct 10.

PMID:
23062667

Supplemental Content

Loading ...
Support Center